Anthony Fauci, former NIAID director testifies during a House Select Subcommittee on the Coronavirus pandemic at Capitol Hill, Monday, June 3, 2024, in Washington. (AP Photo/Mariam Zuhaib)
June 3, 2024 02:31 PM EDT
Pharma
FDA+
Coronavirus

Fau­ci push­es back on pan­dem­ic crit­i­cisms be­fore di­vid­ed House pan­el

Lia DeGroot

Four years af­ter the Covid-19 pan­dem­ic be­gan, the na­tion’s for­mer top in­fec­tious dis­ease of­fi­cial An­tho­ny Fau­ci ap­peared on Mon­day be­fore a pan­el of law­mak­ers to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times